首页> 外文OA文献 >Nanodrug applications in photodynamic therapy.
【2h】

Nanodrug applications in photodynamic therapy.

机译:纳米药物在光动力疗法中的应用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Photodynamic therapy (PDT) has developed over last century and is now becoming a more widely used medical tool having gained regulatory approval for the treatment of various diseases such as cancer and macular degeneration. It is a two-step technique in which the delivery of a photosensitizing drug is followed by the irradiation of light. Activated photosensitizers transfer energy to molecular oxygen which results in the generation of reactive oxygen species which in turn cause cells apoptosis or necrosis. Although this modality has significantly improved the quality of life and survival time for many cancer patients it still offers significant potential for further improvement. In addition to the development of new PDT drugs, the use of nanosized carriers for photosensitizers is a promising approach which might improve the efficiency of photodynamic activity and which can overcome many side effects associated with classic photodynamic therapy. This review aims at highlighting the different types of nanomedical approaches currently used in PDT and outlines future trends and limitations of nanodelivery of photosensitizers.
机译:光动力疗法(PDT)在上个世纪已经发展起来,现在正成为一种更广泛使用的医疗工具,已获得监管机构的批准,用于治疗各种疾病,例如癌症和黄斑变性。这是两步技术,其中在光敏药物的输送之后进行光照射。活化的光敏剂将能量转移至分子氧,从而导致产生活性氧,进而导致细胞凋亡或坏死。尽管这种方式已大大改善了许多癌症患者的生活质量和生存时间,但仍具有进一步改善的巨大潜力。除了开发新的PDT药物外,将纳米级载体用于光敏剂也是一种很有前途的方法,它可以提高光动力活性的效率,并且可以克服与经典光动力疗法相关的许多副作用。这篇综述旨在突出PDT当前使用的不同类型的纳米医学方法,并概述光敏剂纳米递送的未来趋势和局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号